Evidence map›Paper›PMID 38389835›Full record

ArticleTheranostics2024

Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in

Lubna Amer, Maurice Retout, Jesse V Jokerst

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lubna AmerProgram in Materials Science and Engineering, University of California, San Diego, La Jolla, CA 92093, United States.
Maurice RetoutDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093, United States.
Jesse V JokerstProgram in Materials Science and Engineering, University of California, San Diego, La Jolla, CA 92093, United States.
University of California, San Diego · US

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
A Miniaturized and High-frequency Acoustic Imaging System for Oral Health and Diseases of the Head and NeckR01DE031307 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Vincent Jokerst · 2022 to 2026
$3.1M
JEOL JEM-1400Plus Transmission Electron MicroscopeS10OD023527 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FARQUHAR, MARILYN GIST · 2017 to 2017
$579k
Molecular Imaging of Gingipain Activity in Advanced PeriodontitisR21DE029917 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOKERST, JESSE VINCENT · 2020 to 2021
$406k
NIDCR NIH HHS R01 DE031307NIDCR NIH HHS R21 DE029917NIH HHS S10 OD023527NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metal NanoparticlesPeriodontal DiseasesProdrugsAnimalsAntimicrobial PeptidesCandida albicansDelayed-Action PreparationsEndopeptidasesGoldMammalsPeptide HydrolasesPorphyromonas gingivalisSilverAntimicrobial PeptidesDelayed-Action PreparationsEndopeptidasesGoldPeptide HydrolasesProdrugsSilverantimicrobial peptidescontrolled assemblyoral microorganismsplasmonic nanoparticlesprotease sensing

Identifiers

PMID38389835
PMCPMC10879876
OpenAlexW4391984440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.